Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Lamers

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
NPJ Vaccines|January 3, 2024
Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trialManon L M Prins, Geert V T Roozen, Cilia R Pothast, et al.
Journal of Medicinal Chemistry|May 12, 2016
Multiparameter Lead Optimization to Give an Oral Checkpoint Kinase 1 (CHK1) Inhibitor Clinical Candidate: (R)-5-((4-((Morpholin-2-ylmethyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile (CCT245737)James D Osborne, Thomas P Matthews, Tatiana McHardy, et al.
NPJ Vaccines|November 5, 2022
Creation and preclinical evaluation of genetically attenuated malaria parasites arresting growth late in the liverBlandine Franke-Fayard, Catherin Marin-Mogollon, Fiona J A Geurten, et al.
Ebiomedicine|October 14, 2023
Safety and infectivity of female cercariae in Schistosoma-naïve, healthy participants: a controlled human Schistosoma mansoni infection studyJan Pieter R Koopman, Emma L Houlder, Jacqueline J Janse, et al.
Nature Medicine|January 3, 2025
Single immunization with genetically attenuated Pf∆mei2 (GA2) parasites by mosquito bite in controlled human malaria infection: a placebo-controlled randomized trialGeert V T Roozen, Roos van Schuijlenburg, Annefleur D O Hensen, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
NPJ Vaccines|January 3, 2024
Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trialManon L M Prins, Geert V T Roozen, Cilia R Pothast, et al.
Journal of Medicinal Chemistry|May 12, 2016
Multiparameter Lead Optimization to Give an Oral Checkpoint Kinase 1 (CHK1) Inhibitor Clinical Candidate: (R)-5-((4-((Morpholin-2-ylmethyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile (CCT245737)James D Osborne, Thomas P Matthews, Tatiana McHardy, et al.
NPJ Vaccines|November 5, 2022
Creation and preclinical evaluation of genetically attenuated malaria parasites arresting growth late in the liverBlandine Franke-Fayard, Catherin Marin-Mogollon, Fiona J A Geurten, et al.
Ebiomedicine|October 14, 2023
Safety and infectivity of female cercariae in Schistosoma-naïve, healthy participants: a controlled human Schistosoma mansoni infection studyJan Pieter R Koopman, Emma L Houlder, Jacqueline J Janse, et al.
Nature Medicine|January 3, 2025
Single immunization with genetically attenuated Pf∆mei2 (GA2) parasites by mosquito bite in controlled human malaria infection: a placebo-controlled randomized trialGeert V T Roozen, Roos van Schuijlenburg, Annefleur D O Hensen, et al.
Pageof 3